Low Dose Oral Administration of Monosodium Glutamate in Male Albino Rats May be Nephroprotective

Main Article Content

A. C. C. Egbuonu
O. Obidoa
C. A. Ezeokonkwo
L. U. S. Ezeanyika
P. M. Ejikeme

Abstract

The speculation that low dose intake of monosodium glutamate over time may be toxic warranted the present study. The aim was to investigate the effect of the administration of monosodium glutamate at a low concentration on the functional capacity of the kidney. Thus, monosodium glutamate at a dose of 5 mg/kg of body weight was administered to adult male albino rats by oral intubation. Treatment was daily for 28 days. The monosodium glutamate treatment significantly (p < 0.05) decreased the serum sodium ion concentration by 11.38 % and the water intake by 9.39 %, but had no apparent change in the serum potassium ion concentration (change, 0.00 %). The treatment increased (p < 0.05) the serum urea and creatinine concentration by 12.80 % and 107.81 % respectively. Therefore, treating rats with monosodium glutamate at a low concentration (5 mg/kg of body weight) could be nephroprotective, but with possible significant dehydration. The health implications of the results are highlighted in the discussion.

Downloads

Download data is not yet available.

Article Details

How to Cite
Egbuonu, A. C. C., Obidoa, O., Ezeokonkwo, C. A., Ezeanyika, L. U. S., & Ejikeme, P. M. (2025). Low Dose Oral Administration of Monosodium Glutamate in Male Albino Rats May be Nephroprotective. Journal of Biological Research and Biotechnology, 7(1), 470 – 473. https://doi.org/10.4314/br.v7i1.45475
Section
Articles
Author Biography

A. C. C. Egbuonu, Nutrition and Toxicological Biochemistry Laboratory, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria

Phone: +234 8036366565

References

Akio, I. (2000). Transgenic approach to the study of body weight regulation. Pharmacol. Rev. Vol 52: issue (1) 35-62.

Alexander, R.H. and Grifith, J.M. (1992). Clnical/Nutritional Biochemistry. Basic Biochemical Methods. 2nd edn. Wiley-Liss. A John Wiley & Sons Inc. Publication N.Y. Chap.9, 181-317.

Batmanghelidj, F. (2006). Medical report: A new

medical discovery: In Shirley, L., Holistic Healthcare for People and Animals. Available at: ShirleysWellnessCafe.com. Accessed 19/08/2006.

Bergen, H.T., Mizuno, T.M. and Taylor, J. (1998). Hyperphagia and weight gain after gold- thioglucose and monosodium glutamate: relation to hypothalamic neuropeptide. Y. Endocrin. 139: 4483–4488

Bush, B.M. (1991). Interpretation of Laboratory Results for Small Animal Clinicians. Blackwel Scientific Publications. Oxford.

Diniz, Y.S., Fernando, A.A., Campos, K.E., Mani, F., Ribas, B.D. and Novelli, E.L. (2004). Toxicity of hyper caloric diet and monosodium glutamate: oxidative stress and metabolic shifting in hepatic tissue. Food Chem. Toxicol., 42: 319-325.

Goldberg, I. (1994). Functional Foods: Designer Foods, Pharmafoods, Nutraceuticals. Chapman and Hall; New York.

Healthnotes. (2005). MSG Sensitivity, Available online at: www.healthnotes.com as at June 26 2007.

Johnston, D.E. (1999). Special Considerations in Interpreting Liver Function Tests. The Am. Acad. of Family Phys. 59(8), 2223-2232.

Koolman,J. and Roehm, K.H. (2005). Color Atlas of Biochemistry, 2nd edition New York, Thieme p.324 and 336.

Mozes, S., Sefcikova, Z., Lenharde, L. and Raeek, L. (2004). Obesity and changes of alkaline phosphatase activity in the small intestine of 40-80-day old subjects to early postnatal overfeeding of monosodium glutamate. Physiol. Res., 53: 177-186.

Obaseiki-Ebor, E.E., McGhee, E.M. and Shankee, D.M. (2003). Improved detection of the genotoxic and mutagenic potentials of a food condiment A-One (monosodium glutamate). Presented at the Fourth International Conference of the pan-African Environmental Mutagen Society

(PAEMS), Dar El Diafa-Ain Shams University, Cairo Egypt. 2nd-4th March: p. 63.

Olney, J.N. (1969). Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science, 164: 719-721.

Onyema, O.O., Farombi, E.O., Emerole,G.O., Ukoha, A.I. and Onyeze, G.O. (2006). Effect of vitamin E on monosodium glutamate induced hepatoxicity and oxidative stress in rats. Indian J. of Bioch. & Biophys., 43: 20-24.

Panda, N. C. (1989). Kidney. In: Textbook of Biochemistry and Human Biology (2nd edition). GP Talwar, LM Srivastava and KD Moudgil (eds); Prentice-Hall of India. Private Ltd., 276-292.

Rodwell, V.W. (2003). Conversion of amino acids to specialized products In: Catabolism of proteins and of amino acid nitrogen In: Harper’s Illustrated Biochemistry, 26th edn., Murray, R.K., Granner, D.K. and Rodwell, V.W. eds., Chap. 31. McGraw

Hill Companies, New York. 267-268 Rodwell, V.W. and Kennelly, P.J. (2003). Water and pH In: Harper’s Illustrated Biochemistry 26th edn., Murray, R.K., Granner, D.K., Mayes, P.A., and Rodwell, V.W. eds. McGraw Hill Companies, New York. p.5.

Schaumberg, H.H., Byck, R., Gerst, R. Mashman, J.H. (1969). Monosodium L-glutamate, its pharmacology and role in the Chinese restaurant syndrome. Science, 163: 826-828.

Scheffe, H. (1952). An analysis of variance for paired comparisons. J. Am. Statistics Assoc., 47: 381-400.

Scholm, O.W., Jain, M.C. and Carrol, F.J. (1975). Collecting and handling blood for laboratory study In: Scholm O.W., Jain, M.C. and Carrol, F.J ed. Vet. Haematol., Lea and Febiger, Philadelphia. 9-25

TILC (Truth In Labeling Campaign) (a). (June 2, 2004). Neuroendocrine disorders. Available online at: www.truthinlabeling.org TILC (Truth In Labeling Campaign) (b). (July, 3, 2004). Learning and memory disorder. Available online at: www.truthinlabeing.org.

Walker, R. and Lupien, J.R. (2000). The safety evaluation of monosodium glutamate. J. Nutr., 130(4S suppl): 1049-1052S.

Wilding, P. and Kennedy, J.H. (1977). Manual of Routine methods in clinical chemistry for use in intermediate laboratories. WHO

ab./78.1: 25-26.

Similar Articles

You may also start an advanced similarity search for this article.